PANACEA LIFE SCIENCES HOLDINGS, INC. Quarterly Depreciation in USD from Q3 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Panacea Life Sciences Holdings, Inc. quarterly/annual Depreciation history and growth rate from Q3 2018 to Q1 2024.
  • Panacea Life Sciences Holdings, Inc. Depreciation for the quarter ending March 31, 2024 was $383K, a 9.24% decline year-over-year.
  • Panacea Life Sciences Holdings, Inc. Depreciation for the twelve months ending March 31, 2024 was $1.67M, a 0.57% decline year-over-year.
  • Panacea Life Sciences Holdings, Inc. annual Depreciation for 2023 was $1.71M, a 2.59% increase from 2022.
  • Panacea Life Sciences Holdings, Inc. annual Depreciation for 2022 was $1.67M, a 0.36% decline from 2021.
  • Panacea Life Sciences Holdings, Inc. annual Depreciation for 2021 was $1.68M, a 2.77% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.67M $383K -$39.1K -9.24% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $1.71M $444K +$14.2K +3.32% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $1.7M $424K +$2.35K +0.56% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $1.7M $423K +$12.8K +3.13% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-15
Q1 2023 $1.68M $423K +$13.9K +3.39% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $1.67M $429K +$33.9K +8.58% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $1.64M $422K +$29.2K +7.44% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $1.61M $410K -$50.4K -11% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-15
Q1 2022 $1.66M $409K -$18.8K -4.41% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $1.68M $395K -$489K -55.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $2.16M $392K +$21.2K +5.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $2.14M $460K +$112K +32.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $2.03M $428K +$401K +1500% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $1.63M $884K +$870K +6200% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $761K $371K +$346K +1393% Jul 1, 2020 Sep 30, 2020 10-Q/A 2021-12-20
Q2 2020 $414K $348K +$324K +1301% Apr 1, 2020 Jun 30, 2020 10-Q/A 2021-12-20
Q1 2020 $90.5K $26.7K +$26.7K Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-05-27
Q4 2019 $63.8K $14K Oct 1, 2019 Dec 31, 2019 10-K/A 2021-04-23
Q3 2019 $24.9K +$24.9K Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $24.9K Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-18
Q1 2019 $0 Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-30
Q3 2018 $0 Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.